Observational analysis reduces alveolar bone loss in rats with periodontitis, suggesting nanohydrogel may improve antibacterial therapy and immunomodulation.
Periodontal disease is characterized by microbial infection, excessive reactive oxygen species (ROS), and dysregulated inflammatory responses, posing a persistent clinical challenge. Emerging evidence suggests that bacterial infection and ferroptosis─an iron-dependent form of cell death─jointly contribute to inflammation-driven periodontal tissue damage. Here, we present a multifunctional, thermosensitive hydrogel integrating black phosphorus nanosheets (BP NSs) and resveratrol (RSV) for synergistic periodontitis therapy. BP NSs confer near-infrared (NIR) activated photothermal and photodynamic antibacterial properties, along with potent ROS-scavenging capacity. Meanwhile, RSV inhibits ferroptosis by reducing lipid peroxidation and intracellular Fe²⁺ accumulation. The BP-RSV@gel-L system modulates both pro-inflammatory and regenerative cytokine expression, reshapes the inflammatory microenvironment, and promotes the osteogenic differentiation of human periodontal ligament stem cells. In a rat periodontitis model, nanohydrogel markedly attenuated alveolar bone loss and enhanced collagen deposition, which was associated with the suppression of ferroptosis and inflammatory infiltration. This study highlights a nanotherapeutic strategy that integrates antibacterial action, ROS clearance, and ferroptosis-regulating immunomodulation, offering a promising platform for treating chronic inflammatory oral or other diseases.
No takes yet. Share an insight, caveat, or question.
Yuan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: